BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2017 6:16:31 AM | Browse: 1191 | Download: 2127
 |
Received |
|
2017-02-07 09:03 |
|
Peer-Review Started |
|
2017-02-08 15:32 |
|
To Make the First Decision |
|
2017-02-23 09:20 |
|
Return for Revision |
|
2017-02-27 11:08 |
|
Revised |
|
2017-03-18 11:22 |
|
Second Decision |
|
2017-04-11 16:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-04-12 18:05 |
|
Articles in Press |
|
2017-04-12 18:05 |
|
Publication Fee Transferred |
|
2017-04-25 18:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-05-04 13:10 |
|
Publish the Manuscript Online |
|
2017-05-15 06:16 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jang Han Jung, Hyun Jik Lee, Hee Seung Lee, Jung Hyun Jo, In Rae Cho, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song and Seungmin Bang |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Seungmin Bang, MD, PhD, Division of Gastroenterology, Department of Internal Medicine and Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722,
South Korea. bang7028@yuhs.ac |
| Key Words |
Klatskin tumor; Locally advanced; Survival rate; Neoadjuvant therapy; Chemoradiotherapy |
| Core Tip |
This study is a retrospective study to clarify the role of neoadjuvant concurrent chemoradiotherapy (NACCRT) followed by surgical resection for locally advanced perihilar cholangiocarcinoma (CCA). The median disease free survival (DFS) durations of the neoadjuvant and non-neoadjuvant group were 26.0 and 15.1 mo, respectively (p = 0.91). The median overall survival (OS) durations of the neoadjuvant and non-neoadjuvant groups were 32.9 and 27.1 mo, respectively (p = 0.26). However, the NACCRT group showed a downstaging tendency compared to the non-NACCRT group (p = 0.01). This paper will be helpful in the treatment plan for patients with locally advanced perihilar cholangiocarcinoma, especially NACCRT. |
| Publish Date |
2017-05-15 06:16 |
| Citation |
Jung JH, Lee HJ, Lee HS, Jo JH, Cho IR, Chung MJ, Park JY, Park SW, Song SY, Bang S. Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma. World J Gastroenterol 2017; 23(18): 3301-3308 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i18/3301.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i18.3301 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
